Division of Drug Delivery Technology uses NanoSight Characterization System
The group of Professor Wim Jiskoot from the Division of Drug Delivery Technology focuses primarily on vaccine delivery and on protein formulation and characterization with respect to immunogenicity. Nanoparticle size and count is vital to this process and it has selected the NanoSight LM20 to aid their programs.
He describes what is important for his research: “For the vaccine delivery group, it is very important to know the size of the delivery systems as the size can influence the uptake by the cells of the immune system, the diffusion through the skin, the release of vaccine components, and thus the immune response. The group works to develop innovative delivery systems, such as polymeric nanoparticles and liposomes, for the delivery of different types of vaccines through the conventional (injection) or needle-free administration routes (such as transcutaneous or intranasal delivery).”
